Should You Buy CSPC PHARMA (01093) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast 01093 stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast 01093 stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 9.110
Low
0
Averages
0
High
0
0
Current: 9.110
Low
0
Averages
0
High
0
Jefferies
downgrade
$8
AI Analysis
2026-03-27
Reason
Jefferies
Price Target
$8
AI Analysis
2026-03-27
downgrade
Reason
BofA Securities downgraded CSPC Pharmaceutical's rating to 'Underperform' due to a projected decline in revenue and net profit for 2025, alongside downward revisions in earnings per share forecasts for the following years.
China Merchants Securities (HK)
China Merchants Securities (HK)
Buy
downgrade
2026-03-27
Reason
China Merchants Securities (HK)
China Merchants Securities (HK)
Price Target
2026-03-27
downgrade
Buy
Reason
China Merchants Securities (HK) has lowered its target price for CSPC Pharmaceutical Group due to an expected 10.4% decline in total revenue in 2025, primarily driven by volume-based procurement and prescription control. Despite this, the firm maintains a 'Buy' rating as it anticipates stabilization in core domestic sales by 2026 and sees potential for long-term growth through external licensing deals and a differentiated product pipeline.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 01093
